Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
July 26, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
All Press Releases for May 11, 2004 Subscribe to this News Feed      
 

Lupus Markers Subject of BioFrequency Cholesterol Study

The diffusion of reported symptoms associated with lupus, an autoimmune disease, were brought together in a pilot study designed to determine the biofrequency based root cause of lupus.

(PRWEB) May 11, 2004 --The diffusion of reported symptoms associated with lupus, an autoimmune disease, were brought together in a pilot study that was designed to determine the biofrequency based root cause of lupus.

Using computerized vocal samples from a small group of women who suffer from lupus, three common biochemical Frequency Equivalents* were determined: Inositol, aldosterone and corticosterone. Even though these compounds are different in their properties and function within the body, inefficient cholesterol management was found to be the most common, but not the most severe, Lupus marker.

A comparison of each lupus patients vocal profile using cholesterol as a base, revealed that adenosine diphosphate (ADP), Lipoic acid and GABA are the biofrequency root causes of cholesterol insufficiencies associated with Lupus. Each Lupus sufferer would express these defaults individually.

Lupus is a chronic inflammatory disease that can affect various parts of the body, including the skin, joints, blood, and kidneys. Immune response antibodies build up in the tissues and can cause inflammation, injury to tissues, and pain. For some people, lupus is a mild disease affecting only a few organs. For others, it can cause serious and even life-threatening problems.

The Lupus Foundation of American estimates that 500,000 to 1.5 million Americans have been diagnosed with lupus. Sixteen thousand new cases are diagnosed each year. Medical science has not yet developed a cure for lupus but has developed several diverse theories concerning its cause. BioAcoustically Speaking, the frequency pathways of GABA, ADP and Lipoic Acid may be an efficient means to control the cholesterol inefficiency associated with Lupus.

Mary J. Roman, MD, a cardiologist at Cornell University in NY, writes that the association of cholesterol disturbance and Lupus has long been known but is as yet not understood1. Vocal Profiling may be an avenue to determine the biofrequency root associated with many diseases. It must be stressed that individual vocal assessment will be required to reveal individual faults within the basic frequency pathways to be addressed.

There are other secondary issues that must be considered individually for each Lupus sufferer. Additional issues associated with the frequency related Lupus/Cholesterol pathway include Candida, cardiomyopathy, thyroid issues, Parkinson like symptoms, hyperprolinemia, tooth plaque and Kreb cycle insufficiency.

*Frequency Equivalent - a frequency representation of a person, place, thing or emotion.

side bar - Nutrient Information associated with this article –

Inositol is a non-essential vitamin associated with the B complex family of vitamins and is necessary for nerve, brain and muscle metabolism. Inositol is complementary to folic acid, Vitamins B6, B12, choline and methionine and has been associated with inefficient immune response disorders such as Lupus.

Aldosterone is secreted by the cortex of the adrenal gland. It acts on the kidneys to help regulate sodium and blood pressure. Lupus has been associated with defective stimulation of Aldosterone.
Corticosterone imbalances have been associated with Lupus but there has never been a methodology that could determine which of these issues were stressed or why these biochemicals were at issue among Lupus patients as a heterogeneous group.
ADP is involved in DNA repair and apoptosis, both of which may be of relevance in Lupus pathogenesis2.

Lipoic Acid - Lipoic acid is a co factor for the use of ADP and is often recommended as a supplement to lupus treatment.
GABA – gamma aminobutyric acid is referenced in several articles and research papers in association with lupus and DHEA.

Disclaimer: The above considerations are not intended to diagnose, treat or mitigate any disease and are to be treated as frequency related suggestions only. Lupus frequencies associated with Lyme disease are not included here.

References
1. Davis, Jeanie L. Lupus Patients Risk Early Heart Disease. WEBMD Health.
http://my.webmd.com/content/article/78/95854.html
2. Bruce, Ian N., and Ahmad A. Yasmeen. Arthritis Research & Therapy Review: Genetic
epidemiology: Systemic lupus erythematosus .http://arthritis-research.com/content/3/6/331.

Background Information:
Human BioAcoustics is a research modality dedicated to the idea that the voice is a holographic representation of the body. Tapping into the network of nerve pathways from the larynx (voice box) via the vagus nerve to the brain, Frequency Equivalents* are being investigated as a method of diagnostic management to support optimal health and wellness.

Employing fundamental mathematical concepts, Sound Health Inc., an educational research institute, uses biological pathways expressed as frequency relationships to distinguish novel biometric associations.

Vocal Profiling using the tenets of BioAcoustic Biology has been described as being beyond medicine" because of its potential to provide an unsullied glimpse into the inherent form and function of the body.

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
J. Robert Bethel, JD
SOUND HEALTH RESEARCH
740-698-9119
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright